These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 30513504)
1. PSORI-CM02 alleviates IMQ-induced mouse dermatitis via differentially regulating pro- and anti-inflammatory cytokines targeting of Th2 specific transcript factor GATA3. Wu DH; Zhang MM; Li N; Li X; Cai QW; Yu WL; Liu LP; Zhu W; Lu CJ Biomed Pharmacother; 2019 Feb; 110():265-274. PubMed ID: 30513504 [TBL] [Abstract][Full Text] [Related]
2. PSORI-CM02 formula alleviates imiquimod-induced psoriasis via affecting macrophage infiltration and polarization. Li L; Zhang HY; Zhong XQ; Lu Y; Wei J; Li L; Chen H; Lu C; Han L Life Sci; 2020 Feb; 243():117231. PubMed ID: 31887296 [TBL] [Abstract][Full Text] [Related]
3. Anti-Angiogenic Efficacy of PSORI-CM02 and the Associated Mechanism in Psoriasis Lu Y; Yang Y; Zhang J; Zhang H; Ma C; Tang X; Wu J; Li L; Wei J; Chen H; Lu C; Han L Front Immunol; 2021; 12():649591. PubMed ID: 33995368 [TBL] [Abstract][Full Text] [Related]
4. PSORI-CM02 Formula Increases CD4+ Foxp3+ Regulatory T Cell Frequency and Ameliorates Imiquimod-Induced Psoriasis in Mice. Chen H; Liu H; Lu C; Wang M; Li X; Zhao H; Yan Y; Yu W; Han L; Dai Z Front Immunol; 2017; 8():1767. PubMed ID: 29358932 [TBL] [Abstract][Full Text] [Related]
5. Formula PSORI-CM01 inhibits the inflammatory cytokine and chemokine release in keratinocytes via NF-κB expression. Han L; Sun J; Lu CJ; Zhao RZ; Lu Y; Lin HJ; Wei JA Int Immunopharmacol; 2017 Mar; 44():226-233. PubMed ID: 28129604 [TBL] [Abstract][Full Text] [Related]
6. PSORI-CM02 ameliorates psoriasis in vivo and in vitro by inducing autophagy via inhibition of the PI3K/Akt/mTOR pathway. Yue L; Ailin W; Jinwei Z; Leng L; Jianan W; Li L; Haiming C; Ling H; Chuanjian L Phytomedicine; 2019 Nov; 64():153054. PubMed ID: 31401494 [TBL] [Abstract][Full Text] [Related]
7. Chinese Medicine Formula PSORI-CM02 Alleviates Psoriatic Dermatitis via M-MDSCs and Th17 Crosstalk. Deng J; Tan S; Liu R; Yu W; Chen H; Tang N; Han L; Lu C Front Pharmacol; 2020; 11():563433. PubMed ID: 33536902 [TBL] [Abstract][Full Text] [Related]
8. Herbal Components of a Novel Formula PSORI-CM02 Interdependently Suppress Allograft Rejection and Induce CD8+CD122+PD-1+ Regulatory T Cells. Lu C; Liu H; Jin X; Chen Y; Liang CL; Qiu F; Dai Z Front Pharmacol; 2018; 9():88. PubMed ID: 29483872 [TBL] [Abstract][Full Text] [Related]
9. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells. Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075 [TBL] [Abstract][Full Text] [Related]
10. Deciphering the mechanism of PSORI-CM02 in suppressing keratinocyte proliferation through the mTOR/HK2/glycolysis axis. Wang M; Tang B; Huang H; Wu X; Deng H; Chen H; Mei L; Chen X; Burgering B; Lu C Front Pharmacol; 2023; 14():1152347. PubMed ID: 37089953 [TBL] [Abstract][Full Text] [Related]
11. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation. Ma L; Xue H; Qi R; Wang Y; Yuan L J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162 [TBL] [Abstract][Full Text] [Related]
12. Study on Anti-Inflammatory Effect and Major Anti-Inflammatory Components of PSORI-CM02 by Zebrafish Model. Yuan X; Huang L; Lei J; Long Y; Li C Evid Based Complement Alternat Med; 2020; 2020():5604654. PubMed ID: 32595728 [TBL] [Abstract][Full Text] [Related]
13. Formula PSORI-CM01 eliminates psoriasis by inhibiting the expression of keratinocyte cyclin B2. Wei JA; Han L; Lu CJ; Zhao RZ; Sun J; Lu Y; Lin HJ BMC Complement Altern Med; 2016 Jul; 16():255. PubMed ID: 27473420 [TBL] [Abstract][Full Text] [Related]
14. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses. Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437 [TBL] [Abstract][Full Text] [Related]
15. Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells. Meng Y; Wang M; Xie X; Di T; Zhao J; Lin Y; Xu X; Li N; Zhai Y; Wang Y; Li P Int J Mol Med; 2017 May; 39(5):1101-1110. PubMed ID: 28339016 [TBL] [Abstract][Full Text] [Related]
16. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway. Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569 [TBL] [Abstract][Full Text] [Related]
17. Shenghua Decoction reduces uterine bleeding and regulates T-cell paradigm in human deciduas of RU486 medical abortion. Li X; Zhang M; Wang B; Li Y; Wang L; Zhao X; Zhou X; Guo Y; Jiang G; Yao C J Ethnopharmacol; 2013 Dec; 150(3):907-17. PubMed ID: 24140602 [TBL] [Abstract][Full Text] [Related]
18. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways. Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840 [TBL] [Abstract][Full Text] [Related]
19. BuShenYiQi Formula strengthens Th1 response and suppresses Th2-Th17 responses in RSV-induced asthma exacerbated mice. Wang J; Wu J; Kong L; Nurahmat M; Chen M; Luo Q; Li B; Wu X; Dong J J Ethnopharmacol; 2014 May; 154(1):131-47. PubMed ID: 24704667 [TBL] [Abstract][Full Text] [Related]
20. Galangin ameliorates Imiquimod-Induced psoriasis-like skin inflammation in BALB/c mice via down regulating NF-κB and activation of Nrf2 signaling pathways. Sangaraju R; Alavala S; Nalban N; Jerald MK; Sistla R Int Immunopharmacol; 2021 Jul; 96():107754. PubMed ID: 34162135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]